News

Live Science on MSN14h
HIV/AIDS: Facts about the viral infection that attacks the immune system
HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...
ascopubs.org2d
Initial safety run-in results of the phase III POLARGO trial: Polatuzumab vedotin plus rituximab, gemcitabine, and oxaliplatin in patients (pts) with relapsed/refractory ...
Impact of bone marrow involvement in patients with peripheral T-cell lymphoma undergoing autologous stem cell transplant. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This ...